semaglutide glp 1 for Weight Loss Semaglutide vs. Other GLP-1 Receptor

Reddy's became available in Canada on May 15, 2026, while the Apotex version does not yet have a release date [Source: bmj.com/content/393/bmj-2026-597166]

Yazici D, Yapici Eser H, Kiyici S, Sancak S, Sezer H, Uygur M, et al

Allodynia at 1-3% is far less common

While semaglutide itself has not been linked to increased clotting risk, patients prescribed this medication often have multiple independent risk factors for thromboembolism that require clinical attention

doi: 10.1210/en.2016-1334

This difference stems from how insurers classify these drugs - Wegovy is often labeled as a lifestyle drug for weight loss, while Ozempic is approved for treating type 2 diabetes, making it more likely to be covered